BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Effient prasugrel: Additional Phase III data

A subgroup analysis of 1,454 patients treated with Plavix clopidogrel in the Phase III TRITON-TIMI 38 trial showed that patients who were either homozygous for the C3435T variant in the P glycoprotein ( MDR1; ABCB1; P-gp; CD243) gene, cytochrome P450 2C19 (CYP2C19) reduced-function allele carriers, or both (n=681) had a...

Read the full 294 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >